Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
154.2 EUR | -1.46% |
|
+0.44% | +10.08% |
07-12 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
07-12 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ABBVIE INC. | Other Pharmaceuticals | -1.46% | +0.44% | +10.08% | +28.09% | +90.51% | 301B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABBV Stock
- 4AB Stock
- Charts AbbVie Inc.
- Comparison Chart